| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $900.0M | +12.7% |
| Cost of Revenue | $199.7M | +8.8% |
| Gross Profit | $700.4M | +13.9% |
| R&D Expense | $181.6M | +18.6% |
| SG&A Expense | $124.1M | +6.8% |
| Operating Income | -$6.9M | +86.9% |
| Income Tax | $17.4M | +60.0% |
| Net Income | -$36.3M | +53.6% |
| EPS (Basic) | -$0.31 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $328.6M | +38.6% |
| Short-term Investments | $248.5M | +4.9% |
| Accounts Receivable | $258.7M | +17.6% |
| Current Assets | $940.7M | +16.8% |
| Total Assets | $1.74B | +8.4% |
| Current Liabilities | $738.1M | +9.2% |
| Total Liabilities | $1.34B | +6.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $217.5M | +45.1% |
| Capital Expenditures | $4.2M | +149.2% |
| Investing Cash Flow | -$41.4M | +80.5% |
| Financing Cash Flow | -$79.4M | -6447.0% |
| Free Cash Flow | $213.2M | +43.9% |
| +54.4% |
| EPS (Diluted) | -$0.31 | +54.4% |
| Stockholders' Equity |
| $400.0M |
| +15.5% |